IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination

N Engl J Med. 2022 Oct 20;387(16):1524-1527. doi: 10.1056/NEJMc2205667. Epub 2022 Sep 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies*
  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Interleukin 1 Receptor Antagonist Protein* / immunology
  • Myocarditis* / etiology
  • Myocarditis* / immunology
  • SARS-CoV-2
  • Vaccination

Substances

  • Antibodies
  • COVID-19 Vaccines
  • Interleukin 1 Receptor Antagonist Protein